Skip to content

Effect OF Navak Guggulu in the management of Diabetes mellitus

Clinical Evaluation Of Navak Guggulu In Madhumeha (Diabetes Mellitus) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078721
Enrollment
30
Registered
2024-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Bhanu Pratap
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing for trial. 2. Freshly diagnosed and known cases of type 2 Diabetes Mellitus will be taken for study. 3. Patient of age group between 30-60 yrs

Exclusion criteria

Exclusion criteria: 1. Patientswithtype1D.M., insulin dependent type 2 D.M. and blood sugar higher than 300 mg/dl will be excluded. 2. Type2D.M.patientswhowill be insulindependent. 3. Diabeticpatientswithseverecomplicationslikecardiovasculardiseases,Nephropathy,Retinopathy,Diabeticfoot etc. 4. PatientsofGestationaldiabetes. 5. All patients for secondary diabetes mellitus will be excluded for study. 6. Any other patient considered unfit for trial will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Relief in Subjective Parameters 1.Prabhuta Mutrata (Polyuria) 2.AvilaMutrata(Turbidity) 3.Trishnadhikya(Polydypsia) 4.Trishnadhikya(Polydypsia) 5.Kshudhadhikya(Polyphagia) 6.Gala-talu-Shosha(Drynessofmouth) 7.Pindikodweshtana(Cramps) 8.Kara-pada-Suptata(numbnessinhand&feet) 9.Kara-pada-tala-daha(Burningsensationinpalmandsole) 10.Daurbalya(GeneralDebility)Timepoint: 1st Follow up – 15 days post-treatment initiation. 2nd Follow up – 15 days after the 1st Follow up. 3rd Follow up – 15 days after the 2nd Follow up. To observe the effects of treatment or any adverse effect on the patient.

Secondary

MeasureTime frame
relief in objective parameters 1. normal fasting & post prandial blood sugar level 2.urine sugar absenceTimepoint: 1st Follow up – 15 days post-treatment initiation. 2nd Follow up – 15 days after the 1st Follow up. 3rd Follow up – 15 days after the 2nd Follow up. To observe the effects of treatment or any adverse effect on the patient.

Countries

India

Contacts

Public ContactBhanu Pratap

Quadra Institute of Ayurveda and Hospital Roorkee

ayu.abhishek@gmail.com9458636020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026